UNI-EN 32:Information regarding adopted resolutions on the 30th Annual General Meeting
Firma: KRKA, TOVARNA ZDRAVIL D.D.Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 32 | / | 2024 | |||||||
| Date of issue: | 2024-07-11 | ||||||||||
| Short name of the issuer | |||||||||||
| KRKA | |||||||||||
| Subject | |||||||||||
| Information regarding adopted resolutions on the 30th Annual General Meeting | |||||||||||
| Official market - legal basis | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and the relevant legislation Krka, d. d., Novo mesto releases information regarding adopted resolutions on the 30th Annual General Meeting. See the attached document. The notice will be published on the Company's website (www.krka.biz) from 11 July 2024 onwards, for a period of at least 5 years. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Information on adopted resolutions.pdf Information on adopted resolutions.pdf | Information on adopted resolutions | ||||||||||
| KRKA, TOVARNA ZDRAVIL D.D. | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| KRKA | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 8501 | Nove Mesto | ||||||||||||
| (post code) | (city) | ||||||||||||
| Smarjeska | 6 | ||||||||||||
| (street) | (number) | ||||||||||||
| +386 7 331 21 11 | +386 7 332 15 37 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nie dotyczy | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2024-07-11 | Jože Colarič | President of the Management Board and CEO | |||
Cena akcji Krka, tovarna zdravil, d.d., Novo mesto
Cena akcji Krka, tovarna zdravil, d.d., Novo mesto w momencie publikacji komunikatu to 610.0 PLN. Sprawdź ile kosztuje akcja Krka, tovarna zdravil, d.d., Novo mesto aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Krka, tovarna zdravil, d.d., Novo mesto.
